Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Multi-institutional comparison of treatment planning using stereotactic ablative body radiotherapy for hepatocellular carcinoma - benchmark for a prospective multi-institutional study.

Eriguchi T, Takeda A, Oku Y, Ishikura S, Kimura T, Ozawa S, Nakashima T, Matsuo Y, Nakamura M, Matsumoto Y, Yamazaki S, Sanuki N, Ito Y.

Radiat Oncol. 2013 May 4;8:113. doi: 10.1186/1748-717X-8-113.

2.

Stereotactic ablative body radiation therapy with dynamic conformal multiple arc therapy for liver tumors: optimal isodose line fitting to the planning target volume.

Oku Y, Takeda A, Sanuki N, Sudo Y, Oooka Y, Aoki Y, Shimouchi Y, Nishina R, Nomura K, Eriguchi T, Kunieda E.

Pract Radiat Oncol. 2014 Jan-Feb;4(1):e7-e13. doi: 10.1016/j.prro.2013.04.001. Epub 2013 May 24.

PMID:
24621435
3.

Multicentre treatment planning inter-comparison in a national context: The liver stereotactic ablative radiotherapy case.

Esposito M, Maggi G, Marino C, Bottalico L, Cagni E, Carbonini C, Casale M, Clemente S, D'Alesio V, Fedele D, Giglioli FR, Landoni V, Martinotti A, Nigro R, Strigari L, Villaggi E, Mancosu P.

Phys Med. 2016 Jan;32(1):277-83. doi: 10.1016/j.ejmp.2015.09.009. Epub 2015 Oct 20.

PMID:
26498378
4.

Hypofractionated image-guided breath-hold SABR (stereotactic ablative body radiotherapy) of liver metastases--clinical results.

Boda-Heggemann J, Dinter D, Weiss C, Frauenfeld A, Siebenlist K, Attenberger U, Ottstadt M, Schneider F, Hofheinz RD, Wenz F, Lohr F.

Radiat Oncol. 2012 Jun 18;7:92. doi: 10.1186/1748-717X-7-92.

5.

Technical Note: Dosimetric evaluation of Monte Carlo algorithm in iPlan for stereotactic ablative body radiotherapy (SABR) for lung cancer patients using RTOG 0813 parameters.

Pokhrel D, Badkul R, Jiang H, Kumar P, Wang F.

J Appl Clin Med Phys. 2015 Jan 8;16(1):5058. doi: 10.1120/jacmp.v16i1.5058.

PMID:
25679161
6.

[Internal target volume definition using four-dimensional CT and dosimetric evaluation for hepatocellular carcinoma].

Xi M, Liu MZ, Deng XW, Liu H, Huang XY, Zhang L, Li QQ, Hu YH, Cai L, Cui NJ.

Ai Zheng. 2007 Jan;26(1):1-8. Chinese.

PMID:
17222359
7.

Lung stereotactic ablative body radiotherapy: A large scale multi-institutional planning comparison for interpreting results of multi-institutional studies.

Giglioli FR, Strigari L, Ragona R, Borzì GR, Cagni E, Carbonini C, Clemente S, Consorti R, El Gawhary R, Esposito M, Falco MD, Fedele D, Fiandra C, Frassanito MC, Landoni V, Loi G, Lorenzini E, Malisan MR, Marino C, Menghi E, Nardiello B, Nigro R, Oliviero C, Pastore G, Quattrocchi M, Ruggieri R, Redaelli I, Reggiori G, Russo S, Villaggi E, Casati M, Mancosu P.

Phys Med. 2016 Apr;32(4):600-6. doi: 10.1016/j.ejmp.2016.03.015. Epub 2016 Apr 6.

PMID:
27061871
8.

Three-dimensional dosimetric evaluation of a conventional radiotherapy technique for treatment of nasopharyngeal carcinoma.

Chau RM, Teo PM, Choi PH, Cheung KY, Lee WY.

Radiother Oncol. 2001 Feb;58(2):143-53.

PMID:
11166865
9.

Treatment Plan Technique and Quality for Single-Isocenter Stereotactic Ablative Radiotherapy of Multiple Lung Lesions with Volumetric-Modulated Arc Therapy or Intensity-Modulated Radiosurgery.

Quan K, Xu KM, Lalonde R, Horne ZD, Bernard ME, McCoy C, Clump DA, Burton SA, Heron DE.

Front Oncol. 2015 Oct 6;5:213. doi: 10.3389/fonc.2015.00213. eCollection 2015.

10.

A phase I/II trial to evaluate three-dimensional conformal radiation therapy confined to the region of the lumpectomy cavity for Stage I/II breast carcinoma: initial report of feasibility and reproducibility of Radiation Therapy Oncology Group (RTOG) Study 0319.

Vicini F, Winter K, Straube W, Wong J, Pass H, Rabinovitch R, Chafe S, Arthur D, Petersen I, McCormick B.

Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1531-7. Epub 2005 Sep 29.

PMID:
16198508
11.

Dosimetric Consequences of 3D Versus 4D PET/CT for Target Delineation of Lung Stereotactic Radiotherapy.

Siva S, Chesson B, Callahan JW, Hardcastle N, Crawford L, Antippa P, Wright G, MacManus MP, Hicks RJ, Kron T, Ball DL.

J Thorac Oncol. 2015 Jul;10(7):1112-5. doi: 10.1097/JTO.0000000000000555.

12.

Dosimetric comparison of carbon ion radiotherapy and stereotactic body radiotherapy with photon beams for the treatment of hepatocellular carcinoma.

Abe T, Saitoh J, Kobayashi D, Shibuya K, Koyama Y, Shimada H, Shirai K, Ohno T, Nakano T.

Radiat Oncol. 2015 Sep 17;10:187. doi: 10.1186/s13014-015-0491-8.

13.

Dosimetric comparison of brachyablation and stereotactic ablative body radiotherapy in the treatment of liver metastasis.

Pennington JD, Park SJ, Abgaryan N, Banerjee R, Lee PP, Loh C, Lee E, Demanes DJ, Kamrava M.

Brachytherapy. 2015 Jul-Aug;14(4):537-42. doi: 10.1016/j.brachy.2015.04.002. Epub 2015 May 2.

14.

Treatment planning study to determine potential benefit of intensity-modulated radiotherapy versus conformal radiotherapy for unresectable hepatic malignancies.

Eccles CL, Bissonnette JP, Craig T, Taremi M, Wu X, Dawson LA.

Int J Radiat Oncol Biol Phys. 2008 Oct 1;72(2):582-8. doi: 10.1016/j.ijrobp.2008.06.1496.

PMID:
18793961
15.

Feasibility study of stereotactic body radiotherapy for peripheral lung tumors with a maximum dose of 100 Gy in five fractions and a heterogeneous dose distribution in the planning target volume.

Takeda A, Oku Y, Sanuki N, Eriguchi T, Aoki Y, Enomoto T, Kaneko T, Nishimura S, Kunieda E.

J Radiat Res. 2014 Sep;55(5):988-95. doi: 10.1093/jrr/rru037. Epub 2014 May 15.

16.

Dose escalated liver stereotactic body radiation therapy at the mean respiratory position.

Velec M, Moseley JL, Dawson LA, Brock KK.

Int J Radiat Oncol Biol Phys. 2014 Aug 1;89(5):1121-8. doi: 10.1016/j.ijrobp.2014.04.051. Epub 2014 Jul 8.

17.

Dosimetric comparison of stereotactic body radiotherapy using 4D CT and multiphase CT images for treatment planning of lung cancer: evaluation of the impact on daily dose coverage.

Wang L, Hayes S, Paskalev K, Jin L, Buyyounouski MK, Ma CC, Feigenberg S.

Radiother Oncol. 2009 Jun;91(3):314-24. doi: 10.1016/j.radonc.2008.11.018. Epub 2008 Dec 26.

PMID:
19111362
18.

Comparison of Single-fraction and Multi-fraction Stereotactic Radiotherapy for Patients with 18F-fluorodeoxyglucose Positron Emission Tomography-staged Pulmonary Oligometastases.

Siva S, Kirby K, Caine H, Pham D, Kron T, Te Marvelde L, Whalley D, Stevens MJ, Foroudi F, MacManus M, Ball D, Eade T.

Clin Oncol (R Coll Radiol). 2015 Jun;27(6):353-61. doi: 10.1016/j.clon.2015.01.004. Epub 2015 Feb 16.

PMID:
25698068
19.

A multi-institutional study to assess adherence to lung stereotactic body radiotherapy planning goals.

Woerner A, Roeske JC, Harkenrider MM, Fan J, Aydogan B, Koshy M, Laureckas R, Vali F, Campana M, Surucu M.

Med Phys. 2015 Aug;42(8):4629-35. doi: 10.1118/1.4926551.

PMID:
26233190
20.

Stereotactic ablative body radiotherapy for previously untreated solitary hepatocellular carcinoma.

Takeda A, Sanuki N, Eriguchi T, Kobayashi T, Iwabutchi S, Matsunaga K, Mizuno T, Yashiro K, Nisimura S, Kunieda E.

J Gastroenterol Hepatol. 2014 Feb;29(2):372-9. doi: 10.1111/jgh.12350.

PMID:
23927053

Supplemental Content

Support Center